Sign inJoin waitlistJoin the waitlist

Roy Chemaly

Professor, Department Chair and Director of the Clinical Virology Research Program · University of Texas M D Anderson Cancer Center

Credentials: · · · · · ·

History

Department Chair and Director of the Clinical Virology Research program · University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present
University of Washington School of Medicine
Present

2004-2004 Advanced Training Program in Health Care Delivery Research
2004
Infectious Disease
Cleveland Clinic Foundation
1998–2000
Internal Medicine
Staten Island University Hospital
1994–1997
American University Hospital
1993–1994
Al-Arz Hospital
1992–1993
The University of Texas MD Anderson Cancer Center
1988–1992

Research

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Science · 2018 · 3,866 citations
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
New England Journal of Medicine · 2017 · 1,008 citations
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group
Review · The Oncologist · 2020 · 456 citations

Issam Raad
54 papers
Ella Ariza-Heredia
45 papers · 1 as a fellow
Fareed Khawaja
36 papers · 2 as a fellow
Richard Champlin
32 papers
Dimitrios Kontoyiannis
30 papers · 1 as a resident
Victor Mulanovich
30 papers
Elizabeth Shpall
28 papers
GP
Genovefa Papanicolaou
25 papers
Michael Boeckh
23 papers
Amy Spallone
21 papers
Javier Adachi
21 papers
JT
Jeffrey Tarrand
21 papers

Grants

The Interplay of the Immune System, and Microbiome in Determining Outcome of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and in Patients with Leukemia
National Cancer Institute · R01
Contact PI · $518K · University of Tx Md Anderson Can Ctr
2020–2025

Clinical trials

A Multiple Ascending Dose Study of PUL-042 in Stem Cell Transplant Recipients
Principal investigator · Withdrawn · Phase 1
Pulmotect, Inc.
2024–2026
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2021–2028
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
Principal investigator · Completed
Oxford Immunotec
2015–2017
Intravesical Cidofovir for Hemorrhagic Cystitis
Principal investigator · Completed · Phase 1
M.D. Anderson Cancer Center
2013–2016